Constitutive Notch2 signaling induces hepatic tumors in mice
Open Access
- 23 November 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 57 (4) , 1607-1619
Abstract
Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCC) are the most common liver tumors and a leading cause for cancer-related death in men. Notch2 regulates cellular differentiation in the developing and adult liver. Although aberrant Notch signaling is implicated in various cancers, it is still unclear whether Notch2 regulates proliferation and differentiation in liver carcinogenesis and thereby contributes to HCC and CCC formation. Here, we investigated the oncogenic potential of constitutive Notch2 signaling in the liver. We show that liver-specific expression of the intracellular domain of Notch2 (N2ICD) in mice is sufficient to induce HCC formation and biliary hyperplasia. Specifically, constitutive N2ICD signaling in the liver leads to up-regulation of pro-proliferative genes and proliferation of hepatocytes and biliary epithelial cells (BECs). Using the diethylnitrosamine (DEN) HCC carcinogenesis model, we further show that constitutive Notch2 signaling accelerates DEN-induced HCC formation. DEN-induced HCCs with constitutive Notch2 signaling (DENN2ICD HCCs) exhibit a marked increase in size, proliferation, and expression of pro-proliferative genes when compared with HCCs from DEN-induced control mice (DENctrl HCCs). Moreover, DENN2ICD HCCs exhibit increased Sox9 messenger RNA (mRNA) levels and reduced Albumin and Alpha-fetoprotein mRNA levels, indicating that they are less differentiated than DENctrl HCCs. Additionally, DENN2ICD mice develop large hepatic cysts, dysplasia of the biliary epithelium, and eventually CCC. CCC formation in patients and DENN2ICD mice is accompanied by re-expression of hepatocyte nuclear factor 4α(HNF4α), possibly indicating dedifferentiation of BECs. Conclusion : Our data establish an oncogenic role for constitutive Notch2 signaling in liver cancer development.Keywords
This publication has 39 references indexed in Scilit:
- Constitutive Notch2 signaling in neural stem cells promotes tumorigenic features and astroglial lineage entryCell Death & Disease, 2012
- Phenotypic fidelity (or not?) of epithelial cells in the liverHepatology, 2012
- AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathwaysHepatology, 2011
- Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathwayJournal of Experimental Medicine, 2011
- Notch signaling regulates formation of the three‐dimensional architecture of intrahepatic bile ducts in mice†Hepatology, 2010
- Notch Signaling in Solid Tumors2010
- Tumor-specific marker genes for intrahepatic cholangiocarcinoma: Utility and mechanistic insightJournal of Hepatology, 2008
- CholangiocarcinomaHepatology, 2008
- NOTCH2 Mutations Cause Alagille Syndrome, a Heterogeneous Disorder of the Notch Signaling PathwayThe American Journal of Human Genetics, 2006
- Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1Nature Genetics, 1997